ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Clinical Trials, Phase III

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Environment and Public Health ∟ Public Health ∟ Epidemiologic Methods ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III 5 coordinate concepts ∟ Clinical Trials, Phase I \| ∟ Clinical Trials, Phase II \| ∟ Clinical Trials, Phase IV \| ∟ Controlled Clinical Trials \| ∟ Multicenter Studies Medical Subject Headings (MeSH) ∟ Health Care Quality, Access, and Evaluation ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III 5 coordinate concepts ∟ Clinical Trials, Phase I \| ∟ Clinical Trials, Phase II \| ∟ Clinical Trials, Phase IV \| ∟ Controlled Clinical Trials \| ∟ Multicenter Studies Medical Subject Headings (MeSH) ∟ Health Care Quality, Access, and Evaluation ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Evaluation Studies ∟ Clinical Trials ∟ Clinical Trials, Phase III 5 coordinate concepts ∟ Clinical Trials, Phase I \| ∟ Clinical Trials, Phase II \| ∟ Clinical Trials, Phase IV \| ∟ Controlled Clinical Trials \| ∟ Multicenter Studies Medical Subject Headings (MeSH) ∟ Health Occupations ∟ Medicine ∟ Specialties, Medical ∟ Public Health ∟ Epidemiologic Methods ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III 5 coordinate concepts ∟ Clinical Trials, Phase I \| ∟ Clinical Trials, Phase II \| ∟ Clinical Trials, Phase IV \| ∟ Controlled Clinical Trials \| ∟ Multicenter Studies Medical Subject Headings (MeSH) ∟ Health Services Administration ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III 5 coordinate concepts ∟ Clinical Trials, Phase I \| ∟ Clinical Trials, Phase II \| ∟ Clinical Trials, Phase IV \| ∟ Controlled Clinical Trials \| ∟ Multicenter Studies Medical Subject Headings (MeSH) ∟ Health Services Administration ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Evaluation Studies ∟ Clinical Trials ∟ Clinical Trials, Phase III 5 coordinate concepts ∟ Clinical Trials, Phase I \| ∟ Clinical Trials, Phase II \| ∟ Clinical Trials, Phase IV \| ∟ Controlled Clinical Trials \| ∟ Multicenter Studies Medical Subject Headings (MeSH) ∟ Investigative Techniques ∟ Epidemiologic Methods ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III 5 coordinate concepts ∟ Clinical Trials, Phase I \| ∟ Clinical Trials, Phase II \| ∟ Clinical Trials, Phase IV \| ∟ Controlled Clinical Trials \| ∟ Multicenter Studies Medical Subject Headings (MeSH) ∟ Investigative Techniques ∟ Evaluation Studies ∟ Clinical Trials ∟ Clinical Trials, Phase III 5 coordinate concepts ∟ Clinical Trials, Phase I \| ∟ Clinical Trials, Phase II \| ∟ Clinical Trials, Phase IV \| ∟ Controlled Clinical Trials \| ∟ Multicenter Studies Medical Subject Headings (MeSH) ∟ Population Characteristics ∟ Health ∟ Public Health ∟ Epidemiologic Methods ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III 5 coordinate concepts ∟ Clinical Trials, Phase I \| ∟ Clinical Trials, Phase II \| ∟ Clinical Trials, Phase IV \| ∟ Controlled Clinical Trials \| ∟ Multicenter Studies X
Broader terms:	Medical Subject Headings (MeSH) ∟ Environment and Public Health ∟ Public Health ∟ Epidemiologic Methods ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III Medical Subject Headings (MeSH) ∟ Health Care Quality, Access, and Evaluation ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III Medical Subject Headings (MeSH) ∟ Health Care Quality, Access, and Evaluation ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Evaluation Studies ∟ Clinical Trials ∟ Clinical Trials, Phase III Medical Subject Headings (MeSH) ∟ Health Occupations ∟ Medicine ∟ Specialties, Medical ∟ Public Health ∟ Epidemiologic Methods ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III Medical Subject Headings (MeSH) ∟ Health Services Administration ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III Medical Subject Headings (MeSH) ∟ Health Services Administration ∟ Quality of Health Care ∟ Health Care Evaluation Mechanisms ∟ Evaluation Studies ∟ Clinical Trials ∟ Clinical Trials, Phase III Medical Subject Headings (MeSH) ∟ Investigative Techniques ∟ Epidemiologic Methods ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III Medical Subject Headings (MeSH) ∟ Investigative Techniques ∟ Evaluation Studies ∟ Clinical Trials ∟ Clinical Trials, Phase III Medical Subject Headings (MeSH) ∟ Population Characteristics ∟ Health ∟ Public Health ∟ Epidemiologic Methods ∟ Epidemiologic Study Characteristics ∟ Clinical Trials ∟ Clinical Trials, Phase III Clinical Trials > Epidemiologic Study Characteristics > Epidemiologic Methods > Public Health > Environment and Public Health > Medical Subject Headings (MeSH) Clinical Trials > Epidemiologic Study Characteristics > Health Care Evaluation Mechanisms > Quality of Health Care > Health Care Quality, Access, and Evaluation > Medical Subject Headings (MeSH) Clinical Trials > Evaluation Studies > Health Care Evaluation Mechanisms > Quality of Health Care > Health Care Quality, Access, and Evaluation > Medical Subject Headings (MeSH) Clinical Trials > Epidemiologic Study Characteristics > Epidemiologic Methods > Public Health > Specialties, Medical > Medicine > Health Occupations > Medical Subject Headings (MeSH) Clinical Trials > Epidemiologic Study Characteristics > Health Care Evaluation Mechanisms > Quality of Health Care > Health Services Administration > Medical Subject Headings (MeSH) Clinical Trials > Evaluation Studies > Health Care Evaluation Mechanisms > Quality of Health Care > Health Services Administration > Medical Subject Headings (MeSH) Clinical Trials > Epidemiologic Study Characteristics > Epidemiologic Methods > Investigative Techniques > Medical Subject Headings (MeSH) Clinical Trials > Evaluation Studies > Investigative Techniques > Medical Subject Headings (MeSH) Clinical Trials > Epidemiologic Study Characteristics > Epidemiologic Methods > Public Health > Health > Population Characteristics > Medical Subject Headings (MeSH) X
Annotation:	trial lasts about 3 years; for U.S. & foreign studies; for II/III clin trials, index under CLINICAL TRIALS, PHASE II + CLINICAL TRIALS, PHASE III; IM for articles & books about phase III clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE III; DF: CLIN TRIALS PHASE III X
History note:	Clinical Trials (1980-1992)X
historyNote*:	93; DRUG EVALUATION, FDA PHASE III was see CLINICAL TRIALS 1980-92; EVALUATION STUDIES, FDA PHASE III was see CLINICAL TRIALS 1982-92 X
onlineNote*:	use CLINICAL TRIALS to search DRUG EVALUATION, FDA PHASE III 1980-92 & EVALUATION STUDIES, FDA PHASE III 1982-92 X
publicMeSHNote*:	93; DRUG EVALUATION, FDA PHASE III was see CLINICAL TRIALS 1980-92; EVALUATION STUDIES, FDA PHASE III was see CLINICAL TRIALS 1982-92 X
Scope note:	Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries. X
activeMeSHYear*:	2007X
dateCreated*:	1992-05-13X
dateEstablished*:	1993-01-01X
dateRevised*:	2006-07-05X
recordAuthorizer*:	sjnX
recordMaintainer*:	lktX
recordOriginator*:	TPWX
Type:	Concept X
Coordinate terms:	Clinical Trials, Phase I \| Clinical Trials, Phase II \| Clinical Trials, Phase IV \| Controlled Clinical Trials \| Multicenter Studies X
URI:	X
Labels and equivalent concepts:	Kliiniset kokeet, vaihe III (fi) Kliininen koe, vaihe III (fi, replaced) Vaiheen III kliininen koe (fi, replaced) Vaiheen III kliiniset kokeet (fi, replaced) Kliniska prövningar, fas III (sv) Phase III Clinical Trials (en, replaced) Phase 3 Clinical Trials (en, replaced) Drug Evaluation, FDA Phase 3 (en, replaced) Drug Evaluation, FDA Phase III (en, replaced) Evaluation Studies, FDA Phase 3 (en, replaced) Clinical Trials, Phase 3 (en, replaced) X
Share:	X